E-LIB Suche - Ergebnisse für: Mamelok, R

1

26301 Pharmacokinetic analyses show limited systemic exposu..:

Pariser, D.M. ; Lain, E.L. ; Mamelok, R...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB96 , 2021

Link: https://doi.org/10.1016/..

2

Limited Systemic Exposure with Topical Glycopyrronium Tosyl..:

Pariser, D.M. ; Lain, E.L. ; Mamelok, R..
SKIN The Journal of Cutaneous Medicine. 3 (2019) - p. S55 , 2019

Link: https://doi.org/10.25251..

3

Delayed Introduction of Reduced-Dose Tacrolimus, and Renal ..:

Neuberger, J.M. ; Mamelok, R.D. ; Neuhaus, P....
American Journal of Transplantation. 9 (2009) 2 - p. 327-336 , 2009

Link: https://doi.org/10.1111/..

4

UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MP..:

van Schaik, R H N ; van Agteren, M ; de Fijter, J W...
Clinical Pharmacology & Therapeutics. 86 (2009) 3 - p. 319-327 , 2009

Link: https://doi.org/10.1038/..

5

EFFICACY OF MYCOPHENOLATE MOFETIL (MMF) IN LIVER TRANSPLANT..:

Rabkin, J. M. ; Kalayoglu, M. ; Klintmalm, G....
Transplantation. 69 (2000) Supplement - p. S118 , 2000

Link: https://doi.org/10.1097/..

6

Three-Year Allograft Vasculopathy Results of the Multicente..:

Eisen, Howard ; Bourge, R. ; Costanzo, M....
Transplantation. 67 (1999) 7 - p. S268 , 1999

Link: https://doi.org/10.1097/..

7

Three-Year Allograft Vasculopathy Results of the Multicente..:

Eisen, Howard ; Bourge, R. ; Costanzo, M....
Transplantation. 67 (1999) 9 - p. S543 , 1999

Link: https://doi.org/10.1097/..

8

Phase I Study of Amphotericin B Colloidal Dispersion for th..:

Bowden, R. A. ; Cays, M. ; Gooley, T...
Journal of Infectious Diseases. 173 (1996) 5 - p. 1208-1215 , 1996

Link: https://doi.org/10.1093/..

9

Population pharmacokinetics and renal function-sparing effe..:

Amantea, M A ; Bowden, R A ; Forrest, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC162878. , 1995

Link: http://www.ncbi.nlm.nih...

10

Time-dependent clearance of mycophenolic acid in renal tran..:

Hest, R.M. (Reinier) van ; Gelder, T. (Teun) van ; Bouw, R. (René)...
http://repub.eur.nl/pub/36079. , 2007

Link: http://repub.eur.nl/pub/..

11

Limited Systemic Exposure with Topical Glycopyrronium Tosyl..:

Pariser, David M. ; Lain, Edward L. ; Mamelok, Richard D...
Clinical Pharmacokinetics. 60 (2021) 5 - p. 665-676 , 2021

Link: https://doi.org/10.1007/..

12

The pharmacokinetics of mycophenolate mofetil in renal tran..:

Grinyó, Josep M. ; Ekberg, Henrik ; Mamelok, Richard D....
Nephrology Dialysis Transplantation. 24 (2009) 7 - p. 2269-2276 , 2009

Link: https://doi.org/10.1093/..

13

Mycophenolic Acid Exposure after Administration of Mycophen..:

Kuypers, Dirk R. ; Ekberg, Henrik ; Grinyó, Josep...
Clinical Pharmacokinetics. 48 (2009) 5 - p. 329-341 , 2009

Link: https://doi.org/10.2165/..

14

CYP3A5 genotype is not associated with a higher risk of acu..:

Hesselink, Dennis A. ; van Schaik, Ron H.N. ; van Agteren, Madelon...
Pharmacogenetics and Genomics. 18 (2008) 4 - p. 339-348 , 2008

Link: https://doi.org/10.1097/..

15

Kinetics of d-glucose transport into renal membrane vesicle..:

Mamelok, Richard D. ; Macrae, Donald R. ; Hittelman, Karl..
Journal of Biochemical and Biophysical Methods. 4 (1981) 3-4 - p. 147-153 , 1981

Link: https://doi.org/10.1016/..